These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 399976)

  • 1. Current anaplasmosis control techniques in the United States.
    Kuttler KL
    J S Afr Vet Assoc; 1979 Dec; 50(4):314-20. PubMed ID: 399976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three methods of immunization against bovine anaplasmosis: an examination of postvaccinal effects.
    Corrier DE; Vizcaino O; Carson CA; Ristic M; Kuttler KL; Treviño GS; Lee AJ
    Am J Vet Res; 1980 Jul; 41(7):1062-5. PubMed ID: 7436099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis.
    Kuttler KL
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1103-8. PubMed ID: 7216881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods currently used for the control of anaplasmosis and babesiosis: their validity and proposals for future control strategies.
    Lawrence JA; de Vos AJ
    Parassitologia; 1990 Apr; 32(1):63-71. PubMed ID: 2284136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplasmosis: focusing on host-vector-pathogen interactions for vaccine development.
    de la Fuente J; Ayoubi P; Blouin EF; Almazán C; Naranjo V; Kocan KM
    Ann N Y Acad Sci; 2006 Oct; 1078():416-23. PubMed ID: 17114750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis.
    Bakken JS; Dumler JS
    Ann N Y Acad Sci; 2006 Oct; 1078():236-47. PubMed ID: 17114714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects and use of a modified live Anaplasma marginale vaccine in beef heifers in California.
    Henry ET; Norman BB; Fly DE; Wichmann RW; York SM
    J Am Vet Med Assoc; 1983 Jul; 183(1):66-9. PubMed ID: 6874525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three methods of immunization against bovine anaplasmosis: evaluation of protection afforded against field challenge exposure.
    Vizcaino O; Corrier DE; Terry MK; Carson CA; Lee AJ; Kuttler KL; Ristic M; Treviño GS
    Am J Vet Res; 1980 Jul; 41(7):1066-8. PubMed ID: 7436100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phenol on card-agglutination and complement-fixation tests for bovine anaplasmosis.
    Amerault TE; Rose JE; Martin WE; Roby TO
    Am J Vet Res; 1980 Mar; 41(3):435-8. PubMed ID: 7369620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic investigation and control of an epizootic of anaplasmosis in cattle in winter.
    Smith RD; Hungerford LL; Armstrong CT
    J Am Vet Med Assoc; 1989 Aug; 195(4):476-80. PubMed ID: 2777688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplasma ovis in Idaho sheep.
    Magonigle RA; Eckblad WP; Lincoln SD; Frank FW
    Am J Vet Res; 1981 Feb; 42(2):199-201. PubMed ID: 7258767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale.
    Lincoln SD; Zaugg JL; Maas J
    J Am Vet Med Assoc; 1987 Jan; 190(2):171-3. PubMed ID: 3818429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human granulocytic anaplasmosis.
    Bakken JS; Dumler S
    Infect Dis Clin North Am; 2008 Sep; 22(3):433-48, viii. PubMed ID: 18755383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Card agglutination and complement-fixation reactions after vaccination of cattle against anaplasmosis.
    Amerault TE; Roby TO
    J Am Vet Med Assoc; 1971 Dec; 159(12):1749-51. PubMed ID: 5128789
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaplasma marginale field challenge: protection by an inactivated immunogen that shares partial sequence of msp1alpha variable region with the challenge strain.
    Vega LE; Rodríguez SD; Alarcón GJ; Flores RL; Ocampo RJ; Ortiz MA; de la Torre JF; Ramírez EE
    Vaccine; 2007 Jan; 25(3):519-25. PubMed ID: 17049686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplasmosis: a regional serologic survey and oral antibiotic therapy in infected herds.
    Sweet VH; Stauber EH
    J Am Vet Med Assoc; 1978 Jun; 172(11):1310-2. PubMed ID: 659312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an indirect fluorescent antibody test, using microfluorometry as a diagnostic test for bovine anaplasmosis.
    Goff WL; Johnson WC; Kuttler KL
    Am J Vet Res; 1985 May; 46(5):1080-4. PubMed ID: 3890629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.